Anti-alpha 1d Adrenergic Receptor antibody
Be the first to review this product! Submit a review
|
(8 Publications)
Rabbit Polyclonal alpha 1d Adrenergic Receptor antibody. Suitable for WB, IHC-P and reacts with Human samples. Cited in 8 publications. Immunogen corresponding to Synthetic Peptide within Human ADRA1D.
View Alternative Names
ADRA1A, ADRA1D, Alpha-1D adrenergic receptor, Alpha-1A adrenergic receptor, Alpha-1D adrenoreceptor, Alpha-adrenergic receptor 1a, Alpha-1D adrenoceptor
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-alpha 1d Adrenergic Receptor antibody (AB84402)
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) analysis of human cervical cancer tissue labelling alpha 1d Adrenergic Receptor with ab84402 at a dilution of 1/100.
- WB
Unknown
Western blot - Anti-alpha 1d Adrenergic Receptor antibody (AB84402)
All lanes:
Western blot - Anti-alpha 1d Adrenergic Receptor antibody (ab84402) at 1/1000 dilution
Lane 1:
A549 lysate
Lane 2:
MCF7 lysate
Predicted band size: 60 kDa
Observed band size: 60 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The alpha-1d adrenergic receptor promotes vasoconstriction and increases blood pressure through the activation of phospholipase C pathway resulting in calcium release from intracellular stores. It functions as part of a receptor complex that interacts with other alpha-1 adrenergic subtypes such as alpha-1a and alpha-1b adrenergic receptors differentiating their roles in tissue-specific actions. These receptor activities affect muscle contraction and influence systemic vascular resistance.
Pathways
This adrenergic receptor is engaged in the adrenergic signaling in cardiomyocytes and vascular smooth muscle contraction pathways. It facilitates communication between the signaling molecules and cellular responses. The alpha-1d adrenergic receptor partners with proteins like Gq/11 protein family which mediates signal transduction leading to its physiological effects. Interaction with other receptors such as beta-adrenergic receptors shapes the overall cardiovascular outcomes by providing a balance between constriction and relaxation.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (8)
Recent publications for all applications. Explore the full list and refine your search
American journal of physiology. Lung cellular and molecular physiology 324:L639-L651 PubMed36648147
2023
Applications
Unspecified application
Species
Unspecified reactive species
Clinical and translational medicine 12:e890 PubMed35758323
2022
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of the United States of America 119:e2123511119 PubMed35537053
2022
Applications
Unspecified application
Species
Unspecified reactive species
Investigative and clinical urology 61:297-303 PubMed32377606
2020
Applications
Unspecified application
Species
Unspecified reactive species
Circulation research 123:1080-1090 PubMed30355157
2018
Applications
Unspecified application
Species
Unspecified reactive species
Naunyn-Schmiedeberg's archives of pharmacology 389:243-8 PubMed26660071
2015
Applications
Unspecified application
Species
Unspecified reactive species
Proceedings of the National Academy of Sciences of 112:E1659-68 PubMed25775528
2015
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cardiovascular pharmacology 57:263-6 PubMed21107280
2010
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com